Relmada Therapeutics, Inc. (RLMD) Insider Ownership

Historic Insider Ownership Trends

RLMD's three largest insider shareholders as of March 23, 2026 are Sergio Traversa (Chief Executive Officer, 1.30Mn shares), Maged Shenouda (Chief Financial Officer, 800.00K shares), Paul Edward Kelly (Chief Operating Officer, 502.30K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Sergio Traversa Chief Executive Officer 1,300,000 0 16 Dec, 2025
Maged Shenouda Chief Financial Officer 800,000 0 16 Dec, 2025
Paul Edward Kelly Chief Operating Officer 502,295 0 06 Nov, 2025
Chuck Ence Cao And Coo 403,931 0 06 Nov, 2025
Cedric O'Gorman Chief Medical Officer 10,121 0 24 May, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
15 Dec, 2025 Maged Shenouda Common Stock A 11,665 $4.12 800,000 D P
12 Dec, 2025 Chuck Ence Stock Appreciation Rights A 828,000 $0.00 828,000 D A
12 Dec, 2025 Fabiana Fedeli Stock Appreciation Rights A 164,000 $0.00 164,000 D A
12 Dec, 2025 John Glasspool Stock Appreciation Rights A 164,000 $0.00 164,000 D A
15 Dec, 2025 Sergio Traversa Common Stock A 27,500 $4.12 1,300,000 D P
12 Dec, 2025 Paul Edward Kelly Stock Appreciation Rights A 828,000 $0.00 828,000 D A
12 Dec, 2025 Sergio Traversa Stock Appreciation Rights A 1,198,000 $0.00 1,198,000 D A
12 Dec, 2025 Maged Shenouda Stock Appreciation Rights A 828,000 $0.00 828,000 D A
05 Nov, 2025 Paul Edward Kelly Common Stock A 90,000 $2.20 502,295 D P
05 Nov, 2025 Maged Shenouda Common Stock A 500,000 $2.20 788,335 D P
05 Nov, 2025 Sergio Traversa Common Stock A 272,500 $2.20 1,272,500 D P
05 Nov, 2025 Chuck Ence Common Stock A 136,000 $2.20 403,931 D P
26 Aug, 2025 Sergio Traversa Common Stock A 80,545 $0.62 814,569 D P
27 Aug, 2025 Sergio Traversa Common Stock A 129,455 $0.67 944,024 D P
28 Aug, 2025 Sergio Traversa Common Stock A 55,976 $0.74 1,000,000 D P
26 Jun, 2025 Paul Edward Kelly Stock Option (right to buy) A 400,000 $0.00 400,000 D A
26 Jun, 2025 Maged Shenouda Stock Option (right to buy) A 600,000 $0.00 600,000 D A
26 Jun, 2025 John Glasspool Stock Option (right to buy) A 100,000 $0.00 100,000 D A
26 Jun, 2025 Sergio Traversa Stock Option (right to buy) A 800,000 $0.00 800,000 D A
26 Jun, 2025 Fabiana Fedeli Stock Option (right to buy) A 100,000 $0.00 100,000 D A